# Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

> **NCT06549790** · PHASE1 · RECRUITING · sponsor: **Nerviano Medical Sciences** · enrollment: 124 (estimated)

## Conditions studied

- Relapsed/Refractory Acute Myeloid Leukemia

## Interventions

- **DRUG:** NMS-03597812

## Key facts

- **NCT ID:** NCT06549790
- **Lead sponsor:** Nerviano Medical Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-16
- **Primary completion:** 2029-09-15
- **Final completion:** 2030-05-15
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2025-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06549790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06549790, "Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06549790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*